直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Laura P. Masurovsky

Alissa Lipton and Jeffrey Jacobstein on Obviousness-Type Double Patenting

November 10, 2016

By Alissa K. Lipton; Jeffrey M. Jacobstein

Obviousness-type double patenting is a judicially-created doctrine designed to prevent a patent owner from applying for a second patent which isn’t “patentably distinct” from the claims of a first patent. In many cases, obviousness-type double patenting can occur accidentally, and it’s important for patent holders to know how to avoid this complication. In this podcast, Finnegan attorneys Alissa K. Lipton and Jeffrey M. Jacobstein discuss this issue.

Tags

Obviousness (35 USC § 103)

Downloadable Files

  • LiptonJacobsteinObviousnessTypeDoublePatenting

Related Practices

Patent Drafting and Prosecution

Related Industries

生命科學

製藥

生物技術

Related Offices

Boston, MA

Related Professionals

Alissa K. Lipton
Partner
Washington, DC
+1 202 408 4293
Email
Jeffrey M. Jacobstein
Partner
Boston, MA
+1 617 646 1664
Email

Related Insights

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

Virtual Seminar

Patent "Basics" Seminar

May 19, 2026

Virtual

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Conference

2026 Advanced Chemical & Biotech Patent Institute

May 11-12, 2026

San Francisco

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

Webinar

Top Ten Mistakes to Avoid in Negotiating and Drafting License and Collaboration Agreements

May 6, 2026

Webinar

Panel Discussion

Global Patent Strategies & Litigation: An Exclusive Off-the-Record Conversation with Experienced In-House Leaders

May 5, 2026

London

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: March 2026

May 4, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP